Clinical trialNCT02499328CompletedPhase 1/PHASE2Interventional

Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

SponsorAstraZenecaEnrollment340Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dr David Hong, MD
M.D. Anderson Cancer Center
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Research Site
Antwerp, Belgium
Research Site
Brussels, Belgium
Research Site
Brussels, Belgium
Research Site
Edegem, Belgium
Research Site
Namur, Belgium

Germany

Research Site
Berlin, Germany
Research Site
Cologne, Germany
Research Site
Dresden, Germany
Research Site
Frankfurt, Germany
Research Site
Hamburg, Germany
Research Site
Hanover, Germany
Research Site
Jena, Germany
Research Site
München, Germany

Italy

Research Site
Milan, Italy

Spain

Research Site
Barcelona, Spain
Research Site
Hospitalet deLlobregat, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Toledo, Spain

United Kingdom

Research Site
Birmingham, United Kingdom
Research Site
London, United Kingdom
Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom
Research Site
Surrey, United Kingdom
Research Site
Taunton, United Kingdom

United States

Research Site
Birmingham, Alabama, United States
Research Site
Duarte, California, United States
Research Site
La Jolla, California, United States
Research Site
Los Angeles, California, United States
Research Site
Los Angeles, California, United States
Research Site
Orange, California, United States
Research Site
San Francisco, California, United States
Research Site
Denver, Colorado, United States
Research Site
Plantation, Florida, United States
Research Site
Sarasota, Florida, United States
Research Site
Lafayette, Indiana, United States
Research Site
Boston, Massachusetts, United States
Research Site
Detroit, Michigan, United States
Research Site
Billings, Montana, United States
Research Site
Morristown, New Jersey, United States

4 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azd-5069AZD9150 →MEDI4736Tremelimumab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Aug 2015
Primary completion: 28 Feb 2020
Completion: 8 Oct 2025
Last update posted: 11 Feb 2026
Registered enrollment: 340
Registry id: NCT02499328

Cross-registrations

EU-CTR / CTIS (EudraCT)2015-002525-19

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.